Oils, Argania spinosa
|
805-663-7
|
299184-75-1
|
|
Notified C&L
|
View details
|
Glycerol, polymer with methyloxirane
|
940-573-2
|
|
|
Notified C&L
|
View details
|
1,1'-methylenebis[4-isocyanatobenzene] homopolymer, reaction product with n-[3-(trimethoxysilyl)propyl]butylamine
|
940-574-8
|
|
Skin Irrit. 2
Skin Sens. 1
Eye Irrit. 2
Acute Tox. 4
Resp. Sens. 1
STOT SE 3
Carc. 2
STOT RE 2
|
Notified C&L
|
View details
|
1,1'-methylenebis[4-isocyanatobenzene] homopolymer, reaction product with n-[3-(trimethoxysilyl)propyl]butylamine and 2-methyloxirane polymer with oxirane ether with 1,2,3-propanetriol
|
940-575-3
|
|
Skin Irrit. 2
Skin Sens. 1
Eye Irrit. 2
Acute Tox. 4
Resp. Sens. 1
STOT SE 3
Carc. 2
STOT RE 2
|
Notified C&L
|
View details
|
Reaction mass of Butoxypolyethylenepolypropyleneglycol with Fatty acids, C18-unsatd., dimers and with 2-Octyldodecanol
|
940-576-9
|
|
|
Notified C&L
|
View details
|
8-benzyl-8-azabicyclo[3.2.1]octan-3-amine
|
805-664-2
|
96901-92-7
|
|
Notified C&L
|
View details
|
acrylic oligomer
|
805-665-8
|
1184916-69-5
|
|
Notified C&L
|
View details
|
Phenol, 2,2'-[6-(2,4-dibutoxyphenyl)-1,3,5-triazine-2,4-diyl]bis[5-butoxy-
|
805-666-3
|
208343-47-9
|
|
Notified C&L
|
View details
|
[No public or meaningful name is available]
|
940-584-2
|
|
Skin Sens. 1
Aquatic Chronic 3
|
Notified C&L
|
View details
|
[No public or meaningful name is available]
|
940-585-8
|
|
Skin Irrit. 2
Skin Sens. 1
Eye Irrit. 2
Acute Tox. 4
Resp. Sens. 1
STOT SE 3
STOT SE 3
STOT RE 2
STOT RE 2
|
Notified C&L
|
View details
|
19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),4(9),5,7,15(20)-pentaene-14,18-dione
|
805-667-9
|
53544-22-2
|
Muta. 1B
Carc. 1B
Repr. 2
STOT RE 1
STOT RE 1
Aquatic Chronic 4
|
Notified C&L
|
View details
|
(19S)-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
|
805-668-4
|
19685-09-7
|
Muta. 1B
Carc. 1B
Repr. 2
STOT RE 1
STOT RE 1
Aquatic Chronic 4
|
Notified C&L
|
View details
|
Poly(oxy-1,2-ethanediyl), α-sulfo-ω-hydroxy-, C16-18-alkyl ethers, ammonium salts
|
940-586-3
|
|
|
Notified C&L
|
View details
|
[No public or meaningful name is available]
|
940-587-9
|
|
|
Notified C&L
|
View details
|
cyclohexanone monooxygenase
|
805-670-5
|
52037-90-8
|
|
Notified C&L
|
View details
|
Reaction mass of bis(oxiran-2-ylmethyl) terephthalate and tris(oxiran-2-ylmethyl) benzene-1,2,4-tricarboxylate
|
940-592-6
|
|
Acute Tox. 4
Skin Irrit. 2
Skin Sens. 1
Eye Dam. 1
Repr. 2
STOT RE 2
Aquatic Chronic 2
|
REACH registration C&L
|
View details
|
D-pentose, oligomeric, C14 and C18 alkyl glycosides
|
940-643-2
|
|
|
Notified C&L
|
View details
|
Reaction mass of 2-(1,1-dimethylethyl)-4-{[5-(1,1-dimethylethyl)-4-hydroxy-2-methylphenyl]thio}-5-methylphenyl 3-(dodecylthio)propionate and thiobis[2-(1,1-dimethylethyl)-5-methyl-4,1-phenylene] bis[3-(dodecylthio)propionate]
|
940-594-7
|
|
Skin Sens. 1B
STOT RE 1
STOT RE 2
Aquatic Chronic 4
|
REACH registration C&L
|
View details
|
2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl L-valinate hydrochloride monohydrate [1:1:1]
|
805-671-0
|
521915-75-3
|
Acute Tox. 4
Skin Corr. 1B
Eye Dam. 1
|
Notified C&L
|
View details
|
Renewable hydrocarbons of vegetable oil and/or animal fat origin (naphtha type fraction)
|
940-595-2
|
|
Flam. Liq. 2
Asp. Tox. 1
Skin Irrit. 2
STOT SE 3
Carc. 1B
Aquatic Chronic 2
|
REACH registration C&L
|
View details
|
Reaction mass of 226994-27-0 and 7295-85-4
|
940-596-8
|
|
Skin Irrit. 2
Eye Irrit. 2
|
Notified C&L
|
View details
|
imino-methyl-[1-[6-[(3R)-3-methylmorpholin-4-yl]-2-(1H-pyrrolo[2,3-b]pyridin-4-yl)pyrimidin-4-yl]cyclopropyl]-oxo-λ6-sulfane
|
805-672-6
|
1352226-88-0
|
Acute Tox. 4
Muta. 2
Carc. 2
Repr. 1B
STOT SE 1
STOT RE 1
|
Notified C&L
|
View details
|
Reaction mass of 10294-33-4 and 75-09-2
|
940-597-3
|
|
|
Notified C&L
|
View details
|
Bis(3-(hydroxydimethylsilyl)propyl)tetrasulfide
|
805-673-1
|
411223-84-2
|
|
Notified C&L
|
View details
|
ETHYL (1R,2S)-1-AMINO-2-ETHENYLCYCLOPROPANECARBOXYLATE SULPHATE (2:1)
|
940-598-9
|
|
Flam. Sol. 1
Acute Tox. 4
Skin Sens. 1B
Muta. 2
|
Notified C&L
|
View details
|
[No public or meaningful name is available]
|
805-674-7
|
1042695-87-3
|
Acute Tox. 4
Aquatic Chronic 4
|
Notified C&L
|
View details
|
1-[3-(hydroxymethyl)-1-piperidinyl]-3-methyl-1-butanone
|
940-684-6
|
|
|
Notified C&L
|
View details
|
(2R)-2,8-dimethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-1-benzopyran-6-yl-beta-D-Glucopyranoside
|
805-675-2
|
102340-61-4
|
|
Notified C&L
|
View details
|
[No public or meaningful name is available]
|
805-676-8
|
1383448-23-4
|
Acute Tox. 4
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
Notified C&L
|
View details
|
Reaction mass of Benzenesulfonic acid, C10-13-alkyl derivs., sodium salts and pentapotassium bis(peroxymonosulphate) bis(sulphate)
|
940-603-4
|
|
Skin Irrit. 2
Eye Irrit. 2
|
Notified C&L
|
View details
|
4-bromo-6-(trifluoromethoxy)-2-benzothiazolamine
|
940-605-5
|
|
Acute Tox. 2
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
2-[benzyl(2-methyl-2-propanyl)amino]-1-[3,5-bis(benzyloxy)phenyl]ethanone
|
805-677-3
|
52144-92-0
|
|
REACH registration C&L
|
View details
|
Auric
|
940-610-2
|
|
|
Notified C&L
|
View details
|
Auric GMO
|
940-611-8
|
|
|
Notified C&L
|
View details
|
1-N-[4-(dimethylamino)phenyl]-4-N,4-N-dimethylbenzene-1,4-diamine
|
805-678-9
|
637-31-0
|
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
Aquatic Chronic 2
|
Notified C&L
|
View details
|
Reaction mass of sodium chlorite and sodium chlorate and disodium carbonate, compound with hydrogen peroxide (2:3)
|
940-612-3
|
|
Ox. Sol. 2
Acute Tox. 3
Acute Tox. 2
Skin Corr. 1B
Acute Tox. 2
Aquatic Acute 1
|
Notified C&L
|
View details
|
Reaction mass of sodium hydrogensulphate and disodium peroxodisulphate
|
940-613-9
|
|
|
Notified C&L
|
View details
|
2,3-Naphtho-15-crown-5
|
805-679-4
|
17454-47-6
|
Acute Tox. 4
Eye Irrit. 2
Aquatic Chronic 3
|
Notified C&L
|
View details
|
Reaction mass of 127087-87-0 and 7732-18-5
|
940-614-4
|
|
|
Notified C&L
|
View details
|
(Diphenylsiloxane) - dimethylsiloxane vinyl terminated copolymer
|
805-681-5
|
68951-96-2
|
|
Notified C&L
|
View details
|
Reaction mass of 108-88-3 and 18643-08-8
|
940-616-5
|
|
|
Notified C&L
|
View details
|
(Vinylmethylsiloxane) - (octylmethylsiloxane) - dimethylsiloxane terpolymer
|
805-682-0
|
597543-32-3
|
|
Notified C&L
|
View details
|
Reaction mass of 104275-58-3 and 64-17-5
|
940-617-0
|
|
|
Notified C&L
|
View details
|
Polydimethylsiloxane, ethoxy terminated
|
805-683-6
|
70851-25-1
|
|
Notified C&L
|
View details
|
4-Trimethylsilyl-Acetelyt
|
805-684-1
|
16116-87-3
|
|
Notified C&L
|
View details
|
(3-Phenylpropyl)methyldimethoxysilane
|
805-685-7
|
1233513-31-9
|
|
Notified C&L
|
View details
|
(3,3-Dimethylbutyl)trimethoxysilane
|
805-686-2
|
157223-36-4
|
|
Notified C&L
|
View details
|
2-AMINOBENZO[D]OXAZOL-5-YLBORONIC ACID HYDROCHLORIDE
|
940-618-6
|
|
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
(4S,5R)-2-(2,4-dimethoxyphenyl)-3-terbutoxycarbonyl-4-isobutyloxazolidyne-5-carboxylic acid sodium salt
|
805-688-3
|
675584-92-6
|
|
Notified C&L
|
View details
|
(4S)-2-{8-Fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-3,4-dihydroquinazolin-4-yl}acetic acid
|
805-689-9
|
917389-32-3
|
|
Notified C&L
|
View details
|
[No public or meaningful name is available]
|
805-690-4
|
214061-18-4
|
|
Notified C&L
|
View details
|
[No public or meaningful name is available]
|
805-692-5
|
108787-46-8
|
|
Notified C&L
|
View details
|
[No public or meaningful name is available]
|
805-693-0
|
1051970-61-6
|
|
Notified C&L
|
View details
|
[No public or meaningful name is available]
|
805-694-6
|
267878-61-5
|
|
Notified C&L
|
View details
|
[No public or meaningful name is available]
|
805-695-1
|
86044-76-0
|
|
Notified C&L
|
View details
|
[No public or meaningful name is available]
|
805-696-7
|
295350-45-7
|
|
Notified C&L
|
View details
|
[No public or meaningful name is available]
|
805-697-2
|
321709-43-7
|
|
Notified C&L
|
View details
|
[No public or meaningful name is available]
|
805-698-8
|
319432-42-3
|
|
Notified C&L
|
View details
|
[No public or meaningful name is available]
|
805-699-3
|
39064-75-0
|
|
Notified C&L
|
View details
|
[No public or meaningful name is available]
|
805-700-7
|
67019-15-2
|
|
Notified C&L
|
View details
|
(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-3-(1-benzylimidazol-4-yl)-1-[[(2S)-2-carboxy]-3-methyl-1-butan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
|
940-619-1
|
|
|
Notified C&L
|
View details
|
2-Methyl-1H-benzimidazole-5-carboxylic acid hydrochloride
|
805-701-2
|
93089-86-2
|
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
Reaction mass of bis(1,2,2,6,6-pentamethyl-4-piperidyl) sebacate and methyl 1,2,2,6,6-pentamethyl-4-piperidyl sebacate and A mixture of: α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-hydroxypoly(oxyethylene); α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyloxypoly(oxyethylene)
|
940-620-7
|
|
|
Notified C&L
|
View details
|
(2S)-N-[(2R)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
|
940-621-2
|
|
|
Notified C&L
|
View details
|
Ethyl 2,4,6-tri-O-benzoyl-3-O-[(2S)-1-(benzyloxy)-3-cyclohexyl-1oxopropan-2-yl]-1-thio-β-D-galactopyranoside
|
805-702-8
|
322761-81-9
|
|
REACH registration C&L
|
View details
|
(2S)-N-[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
|
940-622-8
|
|
|
Notified C&L
|
View details
|
Boc-Tyr-OMe
|
805-703-3
|
4326-36-7
|
|
Notified C&L
|
View details
|
(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2R)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
|
940-623-3
|
|
|
Notified C&L
|
View details
|
(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-ylamine
|
940-624-9
|
|
|
Notified C&L
|
View details
|
Lithium trihydroxy(1-methyl-1H-pyrazol-5-yl)boranuide
|
940-625-4
|
|
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
[No public or meaningful name is available]
|
805-704-9
|
174728-86-0
|
Skin Sens. 1
Aquatic Chronic 2
|
Notified C&L
|
View details
|
1,3,3-Trimethyl-2-(2-[3-[2-(1,3,3-trimethyl-1,3-dihydro-indol-2-ylidene)-ethylidene]-2-[5-(4-vinyl-benzylsulfanyl)-[1,3,4]thiadiazol-2-ylsulfanyl]-cyclohex-1-enyl]-vinyl)-3H-indolium chloride
|
805-705-4
|
1428320-85-7
|
Acute Tox. 4
Skin Sens. 1
Eye Dam. 1
|
Notified C&L
|
View details
|
[No public or meaningful name is available]
|
805-708-0
|
98728-78-0
|
|
Notified C&L
|
View details
|
Ethylphenethyltrimethoxysilane
|
805-710-1
|
259818-29-6
|
|
Notified C&L
|
View details
|
Reaction mass of 18191-40-7 and 7732-18-5
|
940-629-6
|
|
|
Notified C&L
|
View details
|
Creatine ethyl ester malate
|
940-631-7
|
|
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
[No public or meaningful name is available]
|
805-712-2
|
264233-57-0
|
|
Notified C&L
|
View details
|
Undecanol, branched and linear, ethoxylated, propoxylated (>=2.5 moles EO/PO)
|
940-634-3
|
|
|
Notified C&L
|
View details
|
N-(4-amino-2-ethoxyphenyl)acetamide
|
805-957-5
|
848655-78-7
|
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
REACH registration C&L
|
View details
|
Polydimethylsiloxane, carboxydecyl terminated
|
805-714-3
|
58130-04-4
|
|
Notified C&L
|
View details
|
Poly(octylmethylsiloxane)
|
805-715-9
|
68440-90-4
|
|
Notified C&L
|
View details
|
Poly(N-iso-propyl acrylamide)
|
805-716-4
|
25189-55-3
|
|
Notified C&L
|
View details
|
Reaction mass of 29159-37-3 and 7732-18-5
|
940-636-4
|
|
|
Notified C&L
|
View details
|
p-Dodecyl styrene
|
805-718-5
|
66218-69-7
|
|
Notified C&L
|
View details
|
Octavinyl-T8-silsesquioxane
|
805-719-0
|
69655-76-1
|
|
Notified C&L
|
View details
|
DMAPH-CYCLOHEXANONE
|
940-638-5
|
|
|
Notified C&L
|
View details
|
3,3-DIBUTYL-7-(DIMETHYLAMINO)-4-HYDROXY-5-(4-METHOXYPHENYL)-2,3,4,5-TETRAHYDRO-1$l^{6}-BENZOTHIEPINE-1,1-DIONE
|
940-639-0
|
|
|
Notified C&L
|
View details
|
Reaction mass of 520-26-3 and 520-27-4
|
940-640-6
|
|
|
Notified C&L
|
View details
|
9(10) ketostearic acid
|
940-641-1
|
28726-24-1
|
|
Notified C&L
|
View details
|
3-(6-HYDROXY-2H-1,3-BENZODIOXOL-5-YL)-1,3-DIHYDROINDOL-2-ONE
|
940-645-3
|
|
|
Notified C&L
|
View details
|
methyl 2-methyl-2-phenylpropanoate
|
805-721-1
|
57625-74-8
|
|
REACH registration C&L
|
View details
|
2-(4-cyclopropanecarbonylphenyl)-2-methylpropanoic acid cyclohexylamine salt
|
940-650-0
|
|
|
REACH registration C&L
|
View details
|
3-((5-(3-Acetoxy-2,2-dimethylpropylideneamino)-1,3,3-trimethylcyclohexyl)methylimino)-2,2-dimethylpropyl acetate
|
805-722-7
|
1064082-81-0
|
Skin Sens. 1A
Aquatic Chronic 2
|
REACH registration C&L
|
View details
|
6-BROMOIMIDAZO[1,2-A]PYRIDINE-3-CARBOXYLIC ACID
|
940-651-6
|
|
|
Notified C&L
|
View details
|
3-[4-(ETHYLAMINO)PHENYL]-4-(3-FLUORO-4-HYDROXYPHENYL)-3,4-DIHYDRO-2H-1-BENZOPYRAN-7-OL
|
940-653-7
|
|
|
Notified C&L
|
View details
|
3-(4-AMINOPHENYL)-4-(3-FLUORO-4-HYDROXYPHENYL)-3,4-DIHYDRO-2H-1-BENZOPYRAN-7-OL
|
940-654-2
|
|
|
Notified C&L
|
View details
|
6-FLUORO-3,4-BIS(3-FLUORO-4-HYDROXYPHENYL)-3,4-DIHYDRO-2H-1-BENZOPYRAN-7-OL
|
940-655-8
|
|
|
Notified C&L
|
View details
|
3-[4-(ETHYLAMINO)PHENYL]-6-FLUORO-4-(3-FLUORO-4-HYDROXYPHENYL)-3,4-DIHYDRO-2H-1-BENZOPYRAN-7-OL
|
940-656-3
|
|
|
Notified C&L
|
View details
|
3-(3-HYDROXYPHENYL)-4-(PYRIDIN-4-YL)-3,4-DIHYDRO-2H-1-BENZOPYRAN-7-OL
|
940-657-9
|
|
|
Notified C&L
|
View details
|
3-(3-FLUORO-4-HYDROXYPHENYL)-4-(PYRIDIN-4-YL)-3,4-DIHYDRO-2H-1-BENZOPYRAN-7-OL
|
940-658-4
|
|
|
Notified C&L
|
View details
|
|
|
|
|
|
|